{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:10:23Z","timestamp":1768349423945,"version":"3.49.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Drug-induced liver injury (DILI) caused by Chinese patent medicines is increasing in China. The incidence of invasive fungal infections (IFIs) is increasing due to the suppression of the immune function in greater numbers of patients. Invasive procedures such as deep vein catheterization and the use of glucocorticoids are also predisposing factors to IFIs. The clinical presentation of IFI in teenagers is often atypical, challenging to diagnose, difficult to treat, and associated with a high fatality rate.<\/jats:p><jats:p><jats:bold>Case presentation:<\/jats:bold> Herein, we report 2 teenagers with liver failure after receiving oral Chinese patent medicines. Case 1 was a 14-year-old boy who presented with subacute liver failure who had been administered a Chinese patent medicine that included acetaminophen. Administration of glucocorticoids and non-bioartificial liver treatment improved his condition. Subsequently, invasive pulmonary <jats:italic>Aspergillus<\/jats:italic> (IPA) was diagnosed and was successfully treated with voriconazole for 85\u00a0days. Case 2 was a 17-year-old girl who presented with acute liver failure after taking the Chinese patent medicine QubaiBabuqi tablets for vitiligo. Chest computed tomography (CT) revealed multiple pulmonary nodules with an intermittent low-grade fever, and she was diagnosed with IPA. She was initially treated with caspofungin (23\u00a0days) and then voriconazole (406\u00a0days) for 429\u00a0days. Her liver function returned to normal, and lung lesions were absorbed in 2 patients. At the same time, two to three histopathological examinations of the liver biopsy showed that the drug-induced autoimmune-like phenomena could be improved by glucocorticoid therapy.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> To the best of our knowledge, this is the first report of the successful treatment of 2 cases of liver failure (Child\u2013Pugh class C) caused by Chinese patent medicines complicated with IPA in teenagers. Drug-induced autoimmune-like phenomena could be improved by glucocorticoid therapy.<\/jats:p>","DOI":"10.3389\/fphar.2022.862222","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T05:27:50Z","timestamp":1650432470000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Observation of Voriconazole in the Treatment of Liver Failure Complicated With Invasive Pulmonary Fungal Infection Induced by Chinese Patent Medicine in Teenagers: 2 Case Reports"],"prefix":"10.3389","volume":"13","author":[{"given":"Qian","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/MOP.0000000000000264","article-title":"Drug-induced Liver Injury in Children","volume":"27","author":"Amin","year":"2015","journal-title":"Curr. Opin. Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune Hepatitis: Review of Histologic Features Included in the Simplified Criteria Proposed by the International Autoimmune Hepatitis Group and Proposal for New Histologic Criteria","volume":"30","author":"Balitzer","year":"2017","journal-title":"Mod. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cld.2019.09.005","article-title":"Acute Liver Failure Secondary to Drug-Induced Liver Injury","volume":"24","author":"Chayanupatkul","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality Assessment of Adverse Reactions to Drugs--I. A Novel Method Based on the Conclusions of International Consensus Meetings: Application to Drug-Induced Liver Injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/his.12558","article-title":"Assessment of the Histopathological Key Features in Autoimmune Hepatitis","volume":"66","author":"de Boer","year":"2015","journal-title":"Histopathology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune Hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the Management of Acute (Fulminant) Liver Failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and Fungal Infections in Acute-On-Chronic Liver Failure: Prevalence, Characteristics and Impact on Prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1053\/j.gastro.2016.12.026","article-title":"American Gastroenterological Association Institute Guidelines for the Diagnosis and Management of Acute Liver Failure","volume":"152","author":"Flamm","year":"2017","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified Criteria for the Diagnosis of Autoimmune Hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced Liver Injury: Recent Advances in Diagnosis and Risk Assessment","volume":"66","author":"Kullak Ublick","year":"2017","journal-title":"Gut"},{"key":"B13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrgastro.2011.140","article-title":"Diagnosis: Liver Biopsy Differentiates DILI from Autoimmune Hepatitis","volume":"8","author":"Lewis","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1097\/INF.0000000000002394","article-title":"Invasive Fungal Infections in the Pediatric Intensive Care Unit","volume":"38","author":"Mantadakis","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"w14281","DOI":"10.4414\/smw.2016.14281","article-title":"Common Invasive Fungal Diseases: an Overview of Invasive Candidiasis, Aspergillosis, Cryptococcosis, and Pneumocystis Pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"B17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/liv.13981","article-title":"Invasive Fungal Infections Amongst Patients with Acute-On-Chronic Liver Failure at High Risk for Fungal Infections","volume":"39","author":"Verma","year":"2019","journal-title":"Liver Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijid.2018.05.009","article-title":"Therapeutic Drug Monitoring and Safety of Voriconazole Therapy in Patients with Child-Pugh Class B and C Cirrhosis: A Multicenter Study","volume":"72","author":"Wang","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"647084","DOI":"10.3389\/fphar.2021.647084","article-title":"Research on the Species Difference of the Hepatotoxicity of Medicine Based on Transcriptome","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5009\/gnl14184","article-title":"Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China","volume":"9","author":"Zhu","year":"2015","journal-title":"Gut. Liver"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.862222\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T05:27:54Z","timestamp":1650432474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.862222\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":20,"alternative-id":["10.3389\/fphar.2022.862222"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.862222","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"article-number":"862222"}}